Caxton Associates (UK)’s Progyny PGNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.46M Buy
+293,287
New +$6.55M 0.16% 41
2025
Q4
Sell
-10,806
Closed -$233K 924
2025
Q3
$233K Sell
10,806
-3,801
-26% -$86.4K 0.01% 605
2025
Q2
$321K Sell
14,607
-10,218
-41% -$224K 0.01% 525
2025
Q1
$555K Buy
+24,825
New +$535K 0.02% 453

Other funds holding PGNY

Caxton Associates (UK)'s PGNY Position: Q2 2026 in Review

Caxton Associates (UK) opened a new position in Progyny (PGNY) in Q2 2026: 293,287 shares worth $8.46M. The stake represents 0.16% of the portfolio and ranks #41 among its holdings. This is a return to the name: Caxton Associates (UK) previously reported a position in PGNY as recently as Q3 2025.

Caxton Associates (UK) first reported a position in PGNY in Q1 2025 and has held it in 4 quarters since. 312 funds tracked by Wall St. Rank hold PGNY as of Q2 2026.

  • Caxton Associates (UK) held 293,287 shares of Progyny worth $8.46M as of Q2 2026.
  • Progyny was a new Caxton Associates (UK) position in Q2 2026.
  • Progyny made up 0.16% of Caxton Associates (UK)'s portfolio in Q2 2026, its #41 holding.
  • Caxton Associates (UK) first reported a position in Progyny in Q1 2025 and has held it in 4 quarters since.
  • 312 funds tracked by Wall St. Rank held Progyny as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.